Securities Code: 002898
Securities Abbreviation: SaiLong Delisting
Announcement Number: 2026-075
SaiLong Pharmaceutical Group Co., Ltd.
Third Risk Warning Announcement on the Company's Stock Entering the Delisting Arrangement Period
The Company and the entire Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or significant omissions.
Special Risk Warning:
-
SaiLong Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") will be delisted on the next trading day after the delisting arrangement period ends, and its stock listing will be terminated.
-
The Company's stock resumed trading and entered the delisting arrangement period on June 26, 2026. The delisting arrangement period is fifteen trading days, with the expected last trading day being July 16, 2026. This announcement is disclosed on the tenth trading day. With five remaining trading days, the stock will be delisted upon the expiration of the trading period. Investors are urged to invest prudently and be aware of the risks.
-
During the delisting arrangement period, the Company will not plan or implement any major asset restructuring.
-
Investors, securities companies, and other market participants are requested to settle stock pledge repurchase, agreed repurchase, margin financing, securities lending, and other businesses in a timely manner before the stock is delisted.
-
For judicial freezing businesses that expire after the stock is delisted and before the initial registration period of the delisting board managed by China National Equities Exchange & Quotations Co., Ltd. (NEEQ) on behalf of the original securities companies is completed, it is recommended that the competent authorities complete the renewal of the freezing procedures through the original channels assisting in execution before the stock is delisted.